Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
Rogier A. Oldenburg(Erasmus MC), P. Andrew Futreal(Wellcome Sanger Institute)
Cited by 1,107
Related Papers
The cancer genome
|Nature|2009|3.5k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k